Can lateral neck dissection be withheld if imaging of the lateral neck is negative and there are positive central lymph nodes?
Search Results for: literature review
Optimal Usage of Intratympanic Drug Therapy for Sudden Hearing Loss Unclear
Issues surrounding the therapy include optimal patient selection, the best dosage and duration of therapy and the most effective drugs to use
Otolaryngology Practice Parameter Update: Restless Legs Syndrome
When Is Surgery Indicated for Asymptomatic Primary Hyperparathyroidism?
Once a rare symptomatic disorder characterized by kidney stones, bone loss, neuromuscular disorders and other hypercalcemic signs, PHPT is now appreciated to have a much higher incidence than previously thought, and to usually be only mildly symptomatic or even asymptomatic
Risks and Benefits of CT Scans in Children
A new study again raises the issue of cancer risk with CT scan usage.
New Med School Screening Recommendations to Assess Ethics, Professionalism
The Association of American Medical Colleges is preparing a new slate of recommendations for improving the way med schools screen students in an effort to get at what kind of people the applicants are—and whether they have the qualities that will make them good, caring doctors.
Clinical Guidelines 101
Guidelines are becoming an essential component of clinical care. A look at their development and intended use.
New Sudden Hearing Loss Guidelines Provoke Mixed Opinions
Molecular Testing for Thyroid Nodules Recommended as Adjunct to Fine Needle Aspiration
Drug-Eluting Sinus Stent Hits the Market: May help maintain patency after FESS
Maintaining sinus patency after functional endoscopic sinus surgery (FESS) for chronic rhinosinusitis (CRS) has long been an issue; as many as 23 to 47 percent of patients require revision surgery after FESS. Now, a new drug-eluting, bioabsorbable stent manufactured by Intersect (Palo Alto, Calif.) is being billed as a “breakthrough treatment [that] improves outcomes for sinus surgery,” according to a news release from the company. The device, which received pre-market approval from the U.S. Food and Drug Administration (FDA) in August, has been studied since 2008. It is currently available in Texas, New York, Philadelphia, New Jersey, Atlanta, Ohio and Kentucky.
- « Previous Page
- 1
- …
- 36
- 37
- 38
- 39
- 40
- …
- 45
- Next Page »